Spatially resolved integrated omics profiling for ADC targets in Urothelial Carcinoma

Spatially resolved integrated omics profiling for ADC targets in Urothelial Carcinoma

Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity

IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma

Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics

ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma

Altered inflammatory mucosal signatures within their spatial and cellular context during active ileal Crohn’s disease

Understanding the Role of the Immune Contexture in Invasion and Metastasis of Solid Tumors Using Multiplexed Immunofluorescence and Image Analysis

Understanding the Role of the Immune Contexture in Invasion and Metastasis of Solid Tumors Using Multiplexed Immunofluorescence and Image Analysis

Multiomic mapping of the brain: same-section, fully-automated spatial RNA and protein detection on mouse frozen tissues

Multiomic mapping of the brain: same-section, fully-automated spatial RNA and protein detection on mouse frozen tissues

ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for 1 Pancreatic Ductal Adenocarcinoma